Indication: For the treatment of: 1. All stages of essential hypertension 2. Renal vascular hypertension 3. All levels of heart failure For patients with symptomatic heart failure, it is also suitable for: improving survival rate: delaying the progression of heart failure; reducing hospitalization due to heart failure. 4. Preventing symptomatic heart failure For patients with asymptomatic left ventricular dysfunction, it is suitable for: delaying the progression of symptomatic heart failure: reducing hospitalization due to heart failure. 5. Preventing coronary ischemic events in patients with left ventricular dysfunction. It is suitable for: reducing the incidence of myocardial infarction: reducing hospitalization due to unstable angina.

Indication: Used to treat essential hypertension.

Indication: (1) Hypertension. This product can be used alone or in combination with other antihypertensive drugs. (2) Chronic stable angina pectoris and variant angina pectoris. This product can be used alone or in combination with other antianginal drugs.

Indication: This product is used in combination with heparin to prevent cardiac ischemic events in patients with unstable angina or non-Q wave myocardial infarction. It is also suitable for patients with coronary ischemic syndrome undergoing coronary angioplasty or intracoronary plaque resection to prevent cardiac ischemic complications related to sudden occlusion of the treated coronary artery.

Indication: It is suitable for patients with unstable angina or non-Q wave myocardial infarction to prevent cardiac ischemic events. It is also suitable for patients with coronary ischemic syndrome undergoing coronary angioplasty or intracoronary plaque resection to prevent cardiac ischemic complications related to sudden occlusion of treated coronary arteries.

Indication: Tirofiban combined with heparin is indicated for the prevention of myocardial ischemic events in patients with unstable angina or non-Q wave myocardial infarction. It is also indicated for the prevention of cardiac ischemic complications associated with sudden occlusion of the treated coronary artery in patients with coronary ischemic syndrome undergoing coronary angioplasty or intracoronary plaque resection.

Indication: It is suitable for left ventricular failure secondary to acute myocardial infarction, left ventricular failure caused by various causes, and severe or unstable angina pectoris.

Indication: It is suitable for left ventricular failure secondary to acute myocardial infarction, left ventricular failure caused by various causes, and severe or unstable angina pectoris.

Indication: It is suitable for left ventricular failure secondary to acute myocardial infarction, left ventricular failure caused by various causes, and severe or unstable angina pectoris.

Indication: Treatment of acute deep vein thrombosis. Prevention of coagulation in the extracorporeal circulation system during hemodialysis and hemofiltration in patients with acute renal failure or chronic renal insufficiency. Unstable coronary heart disease, such as unstable angina and non-Q-wave myocardial infarction. Prevention of thrombosis related to surgery.